BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8819199)

  • 1. Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood.
    Galbraith EA; McKellar QA
    Res Vet Sci; 1996 Jul; 61(1):78-81. PubMed ID: 8819199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production.
    Soma LR; Uboh CE; Rudy J; Fegely J
    J Vet Pharmacol Ther; 1992 Sep; 15(3):292-300. PubMed ID: 1433493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.
    McKellar QA; Galbraith EA; Bogan JA; Russell CS; Hooke RE; Lees P
    Vet Rec; 1989 Jun; 124(25):651-4. PubMed ID: 2763429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin.
    Jackman BR; Moore JN; Barton MH; Morris DD
    Can J Vet Res; 1994 Apr; 58(2):138-43. PubMed ID: 8004539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
    Brideau C; Van Staden C; Chan CC
    Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.
    Semrad SD; Hardee GE; Hardee MM; Moore JN
    Am J Vet Res; 1985 Dec; 46(12):2474-9. PubMed ID: 4083579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses.
    Semrad SD; Hardee GE; Hardee MM; Moore JN
    Equine Vet J; 1987 May; 19(3):201-6. PubMed ID: 3608957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.
    Colahan PT; Bailey JE; Chou CC; Johnson M; Rice BL; Jones GL; Cheeks JP
    Vet Ther; 2002; 3(1):37-48. PubMed ID: 12050827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
    Lees P; Ewins CP; Taylor JB; Sedgwick AD
    Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life.
    Semrad SD; Sams RA; Ashcraft SM
    Am J Vet Res; 1993 Dec; 54(12):2083-7. PubMed ID: 8116942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
    Beretta C; Garavaglia G; Cavalli M
    Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of flunixin meglumine on plasma prostanoid concentrations in horses with colic in the perioperative period].
    Gerdemann R; Deegen E; Kietzmann M; Venner M
    Dtsch Tierarztl Wochenschr; 1997 Sep; 104(9):365-8. PubMed ID: 9410724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Inflammation; 1993 Aug; 17(4):417-25. PubMed ID: 8406686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
    Cook VL; Meyer CT; Campbell NB; Blikslager AT
    Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.
    Duz M; Parkin TD; Cullander RM; Marshall JF
    Am J Vet Res; 2015 Mar; 76(3):208-15. PubMed ID: 25710756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.
    Knych HK; Arthur RM; McKemie DS; Chapman N
    J Vet Pharmacol Ther; 2015 Aug; 38(4):313-20. PubMed ID: 25582761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
    Landoni MF; Lees P
    Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
    Ziegler AL; Freeman CK; Fogle CA; Burke MJ; Davis JL; Cook VL; Southwood LL; Blikslager AT
    Equine Vet J; 2019 May; 51(3):329-335. PubMed ID: 30156312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.